Literature DB >> 25746002

An EGFR/PI3K/AKT axis promotes accumulation of the Rac1-GEF Tiam1 that is critical in EGFR-driven tumorigenesis.

G Zhu1,2, Z Fan1, M Ding3, H Zhang4, L Mu1,4, Y Ding1, Y Zhang5, B Jia6, L Chen4, Z Chang5, W Wu1.   

Abstract

Epidermal growth factor receptor (EGFR) signaling regulates cell growth and survival, and its overactivation drives cancer development. One important branch of EGFR signaling is through activation of GTPase Rac1, which further promotes cell proliferation, survival and cancer metastasis. Here, we show that EGFR activates Rac1 via inducing the accumulation of its specific guanine nucleotide exchange factor, T-cell lymphoma invasion and metastasis 1 (Tiam1) in non-small-cell lung cancer and colon cancer cells. Conversely, elevated Tiam1 is required for EGFR-induced tumorigenesis. In human lung adenocarcinoma and colon cancer specimens, Tiam1 expression strongly correlates with EGFR expression. We further reveal that AKT, a key downstream protein kinase of EGFR, phosphorylates Tiam1 at several consensus sites, facilitates the interaction of Tiam1 with scaffold proteins 14-3-3 and leads to an increase of Tiam1 stability. Subsequently, Tiam1 is dephosporylated and destabilized by PP2A. Together, our study identifies a bidirectional (phosphorylation and dephosphorylation) regulatory mechanism controlling Tiam1 stability and provides new insights on how EGFR signaling triggers Rac1 activation and cancer development.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25746002     DOI: 10.1038/onc.2015.45

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  61 in total

1.  Rational design and characterization of a Rac GTPase-specific small molecule inhibitor.

Authors:  Yuan Gao; J Bradley Dickerson; Fukun Guo; Jie Zheng; Yi Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

Review 2.  Tyrosine kinases as targets for cancer therapy.

Authors:  Daniela S Krause; Richard A Van Etten
Journal:  N Engl J Med       Date:  2005-07-14       Impact factor: 91.245

3.  Resistance to EGFR-targeted therapy: a family affair.

Authors:  Gregory Vlacich; Robert J Coffey
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

4.  Modulation of Akt kinase activity by binding to Hsp90.

Authors:  S Sato; N Fujita; T Tsuruo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

5.  Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer.

Authors:  Maria Soledad Sosa; Cynthia Lopez-Haber; Chengfeng Yang; Hongbin Wang; Mark A Lemmon; John M Busillo; Jiansong Luo; Jeffrey L Benovic; Andres Klein-Szanto; Hiroshi Yagi; J Silvio Gutkind; Ramon E Parsons; Marcelo G Kazanietz
Journal:  Mol Cell       Date:  2010-12-22       Impact factor: 17.970

Review 6.  RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis.

Authors:  Hemant K Bid; Ryan D Roberts; Parmeet K Manchanda; Peter J Houghton
Journal:  Mol Cancer Ther       Date:  2013-09-26       Impact factor: 6.261

7.  Tumor growth inhibition with cetuximab and chemotherapy in non-small cell lung cancer xenografts expressing wild-type and mutated epidermal growth factor receptor.

Authors:  Philipp Steiner; Christopher Joynes; Rajiv Bassi; Su Wang; James R Tonra; Yaron R Hadari; Daniel J Hicklin
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

Review 8.  Rho GTPases in cancer cell biology.

Authors:  Francisco M Vega; Anne J Ridley
Journal:  FEBS Lett       Date:  2008-05-05       Impact factor: 4.124

9.  EGFR inhibition in glioma cells modulates Rho signaling to inhibit cell motility and invasion and cooperates with temozolomide to reduce cell growth.

Authors:  Guillem Ramis; Elena Thomàs-Moyà; Silvia Fernández de Mattos; José Rodríguez; Priam Villalonga
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

10.  Regulated membrane localization of Tiam1, mediated by the NH2-terminal pleckstrin homology domain, is required for Rac-dependent membrane ruffling and C-Jun NH2-terminal kinase activation.

Authors:  F Michiels; J C Stam; P L Hordijk; R A van der Kammen; L Ruuls-Van Stalle; C A Feltkamp; J G Collard
Journal:  J Cell Biol       Date:  1997-04-21       Impact factor: 10.539

View more
  40 in total

1.  Rac1 is a potential target to circumvent radioresistance.

Authors:  Wen-Ling Wang; Wei-Chien Huang
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

2.  Both sides of the same coin: Rac1 splicing regulating by EGF signaling.

Authors:  Xiang-Dong Fu
Journal:  Cell Res       Date:  2017-02-10       Impact factor: 25.617

Review 3.  The role of Rac in tumor susceptibility and disease progression: from biochemistry to the clinic.

Authors:  Victoria Casado-Medrano; Martin J Baker; Cynthia Lopez-Haber; Mariana Cooke; Shaofei Wang; Maria J Caloca; Marcelo G Kazanietz
Journal:  Biochem Soc Trans       Date:  2018-07-31       Impact factor: 5.407

Review 4.  Regulating Rho GTPases and their regulators.

Authors:  Richard G Hodge; Anne J Ridley
Journal:  Nat Rev Mol Cell Biol       Date:  2016-06-15       Impact factor: 94.444

5.  High expression of Nectin-4 is associated with unfavorable prognosis in gastric cancer.

Authors:  Yan Zhang; Jiaxuan Zhang; Qin Shen; Wei Yin; Hua Huang; Yifei Liu; Qingfeng Ni
Journal:  Oncol Lett       Date:  2018-03-28       Impact factor: 2.967

6.  PLEKHG3 enhances polarized cell migration by activating actin filaments at the cell front.

Authors:  Trang Thi Thu Nguyen; Wei Sun Park; Byung Ouk Park; Cha Yeon Kim; Yohan Oh; Jin Man Kim; Hana Choi; Taeyoon Kyung; Cheol-Hee Kim; Gabsang Lee; Klaus M Hahn; Tobias Meyer; Won Do Heo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-23       Impact factor: 11.205

7.  AKT inhibition-mediated dephosphorylation of TFE3 promotes overactive autophagy independent of MTORC1 in cadmium-exposed bone mesenchymal stem cells.

Authors:  Huifeng Pi; Min Li; Lingyun Zou; Min Yang; Ping Deng; Tengfei Fan; Menyu Liu; Li Tian; Manyu Tu; Jia Xie; Mengyan Chen; Huijuan Li; Yu Xi; Lei Zhang; Mindi He; Yonghui Lu; Chunhai Chen; Tao Zhang; Zheng Wang; Zhengping Yu; Feng Gao; Zhou Zhou
Journal:  Autophagy       Date:  2018-10-20       Impact factor: 16.016

8.  CUE domain-containing protein 2 promotes the Warburg effect and tumorigenesis.

Authors:  Xiuying Zhong; Shengya Tian; Xiang Zhang; Xinwei Diao; Fangting Dong; Jie Yang; Zhaoyong Li; Linchong Sun; Lin Wang; Xiaoping He; Gongwei Wu; Xin Hu; Lihua Wang; Libing Song; Huafeng Zhang; Xin Pan; Ailing Li; Ping Gao
Journal:  EMBO Rep       Date:  2017-03-21       Impact factor: 8.807

9.  The tuberous sclerosis complex subunit TBC1D7 is stabilized by Akt phosphorylation-mediated 14-3-3 binding.

Authors:  James P Madigan; Feng Hou; Linlei Ye; Jicheng Hu; Aiping Dong; Wolfram Tempel; Marielle E Yohe; Paul A Randazzo; Lisa M Miller Jenkins; Michael M Gottesman; Yufeng Tong
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

Review 10.  RHOB expression controls the activity of serine/threonine protein phosphatase PP2A to modulate mesenchymal phenotype and invasion in non-small cell lung cancers.

Authors:  Olivier Calvayrac; Anne Pradines; Gilles Favre
Journal:  Small GTPases       Date:  2016-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.